BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

May 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-05-16

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-16	Common Stock	S	1004	$56.9082	Disposed	20980	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on December 12, 2013.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $56.15 to $57.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold t each price within the range.